Endocannabinoids in cognition and dependence

This publication has 116 references indexed in Scilit:

• SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
  Published by Wiley ,2001
• Effects of chronic Δ9-tetrahydrocannabinol treatment on hippocampal extracellular acetylcholine concentration and alternation performance in the T-maze
  Neuropharmacology, 2001
• D₂ dopamine receptors enable Δ⁹‐tetrahydrocannabinol induced memory impairment and reduction of hippocampal extracellular acetylcholine concentration
  British Journal of Pharmacology, 2000
• Brain Regional Distribution of Endocannabinoids: Implications for Their Biosynthesis and Biological Function
  Biochemical and Biophysical Research Communications, 1999
• Δ9-Tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance
  Published by Elsevier ,1998
• Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat
  FEBS Letters, 1996
• The endogenous cannabinoid receptor agonist anandamide impairs memory in rats
  Behavioural Pharmacology, 1996
• Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain
  Life Sciences, 1996
• Acute effects of marijuana smoke on complex operant behavior in rhesus monkeys
  Life Sciences, 1989
• CLONIDINE BLOCKS ACUTE OPIATE-WITHDRAWAL SYMPTOMS
  The Lancet, 1978